Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gluconeogenesis is a metabolic pathway by which organisms synthesize glucose from non-carbohydrate precursors, ensuring a continuous supply of glucose during periods of fasting, intense exercise, or low-carbohydrate intake. This pathway primarily occurs in the liver and to a lesser extent in the kidney cortex. Key enzymes involved include pyruvate carboxylase, phosphoenolpyruvate carboxykinase (PEPCK), fructose 1,6-bisphosphatase, and glucose-6-phosphatase. Gluconeogenesis is tightly regulated by hormones (glucagon, insulin, cortisol) and allosteric effectors. Disorders affecting gluconeogenic enzymes can lead to hypoglycemia or metabolic imbalances. Overactive gluconeogenesis contributes significantly to hyperglycemia seen in type 2 diabetes mellitus.
Regulation of gluconeogenic enzymes (e.g., inhibition of PEPCK or G6Pase)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gluconeogenesis.